Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis

Title
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis
Authors
Keywords
Hangeshashinto, TJ-14, Colorectal Cancer, Oral mucositis
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 76, Issue 1, Pages 97-103
Publisher
Springer Nature
Online
2015-05-16
DOI
10.1007/s00280-015-2767-y

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started